contributors
Author: Arthur Allen
Author
-
July 7, 2023
Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients
With the FDA’s approval of lecanemab, Eisai is set to promote it to the primary care physicians who treat most dementia patients and critics are speaking out.Read More →: Why the Next Big Hope for Alzheimer’s Might Not Help Most Black Patients